Global Live Attenuated Vaccines Market Research Report 2023(Status and Outlook)

Global Live Attenuated Vaccines Market Research Report 2023(Status and Outlook)



Report Overview

An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or ""live""). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by ""killing"" the virus (inactivated vaccine).

Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.

The Global Live Attenuated Vaccines Market Size was estimated at USD 25940 million in 2022 and is projected to reach USD 39262.47 million by 2029, exhibiting a CAGR of 6.10% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Live Attenuated Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Live Attenuated Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Live Attenuated Vaccines market in any manner.

Global Live Attenuated Vaccines Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GlaxoSmithKline

Merck

Pfizer

Astellas Pharma

Johnson & Johnson

CSL

Sanofi

Serum Institute Of India

Market Segmentation (by Type)

Bacterial

Viral

Market Segmentation (by Application)

Construction

Communication

Electric Power

Transportation

Oil and Gas

Others

By Company

Phoenix

ABB

Emerson

Siemens

Eaton

Schneider

ZG

Citel

General Electric

Mersen Electrical

Littelfuse

nVent

Philips

LEIAN

MVC-Maxivolt

Leviton

Raycap

HPXIN

Legrand

MIG

MCG Surge Protection

Hubbell

Tripp Lite

KEANDA

JMV

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Live Attenuated Vaccines Market

Overview of the regional outlook of the Live Attenuated Vaccines Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Live Attenuated Vaccines
1.2 Key Market Segments
1.2.1 Live Attenuated Vaccines Segment by Type
1.2.2 Live Attenuated Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Live Attenuated Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Live Attenuated Vaccines Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Live Attenuated Vaccines Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Live Attenuated Vaccines Market Competitive Landscape
3.1 Global Live Attenuated Vaccines Sales by Manufacturers (2018-2023)
3.2 Global Live Attenuated Vaccines Revenue Market Share by Manufacturers (2018-2023)
3.3 Live Attenuated Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Live Attenuated Vaccines Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Live Attenuated Vaccines Sales Sites, Area Served, Product Type
3.6 Live Attenuated Vaccines Market Competitive Situation and Trends
3.6.1 Live Attenuated Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Live Attenuated Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Live Attenuated Vaccines Industry Chain Analysis
4.1 Live Attenuated Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Live Attenuated Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Live Attenuated Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Attenuated Vaccines Sales Market Share by Type (2018-2023)
6.3 Global Live Attenuated Vaccines Market Size Market Share by Type (2018-2023)
6.4 Global Live Attenuated Vaccines Price by Type (2018-2023)
7 Live Attenuated Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Attenuated Vaccines Market Sales by Application (2018-2023)
7.3 Global Live Attenuated Vaccines Market Size (M USD) by Application (2018-2023)
7.4 Global Live Attenuated Vaccines Sales Growth Rate by Application (2018-2023)
8 Live Attenuated Vaccines Market Segmentation by Region
8.1 Global Live Attenuated Vaccines Sales by Region
8.1.1 Global Live Attenuated Vaccines Sales by Region
8.1.2 Global Live Attenuated Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Live Attenuated Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Live Attenuated Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Live Attenuated Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Live Attenuated Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Live Attenuated Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Live Attenuated Vaccines Basic Information
9.1.2 GlaxoSmithKline Live Attenuated Vaccines Product Overview
9.1.3 GlaxoSmithKline Live Attenuated Vaccines Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Live Attenuated Vaccines SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
9.2 Merck
9.2.1 Merck Live Attenuated Vaccines Basic Information
9.2.2 Merck Live Attenuated Vaccines Product Overview
9.2.3 Merck Live Attenuated Vaccines Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Live Attenuated Vaccines SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Pfizer
9.3.1 Pfizer Live Attenuated Vaccines Basic Information
9.3.2 Pfizer Live Attenuated Vaccines Product Overview
9.3.3 Pfizer Live Attenuated Vaccines Product Market Performance
9.3.4 Pfizer Business Overview
9.3.5 Pfizer Live Attenuated Vaccines SWOT Analysis
9.3.6 Pfizer Recent Developments
9.4 Astellas Pharma
9.4.1 Astellas Pharma Live Attenuated Vaccines Basic Information
9.4.2 Astellas Pharma Live Attenuated Vaccines Product Overview
9.4.3 Astellas Pharma Live Attenuated Vaccines Product Market Performance
9.4.4 Astellas Pharma Business Overview
9.4.5 Astellas Pharma Live Attenuated Vaccines SWOT Analysis
9.4.6 Astellas Pharma Recent Developments
9.5 Johnson andamp; Johnson
9.5.1 Johnson andamp; Johnson Live Attenuated Vaccines Basic Information
9.5.2 Johnson andamp; Johnson Live Attenuated Vaccines Product Overview
9.5.3 Johnson andamp; Johnson Live Attenuated Vaccines Product Market Performance
9.5.4 Johnson andamp; Johnson Business Overview
9.5.5 Johnson andamp; Johnson Live Attenuated Vaccines SWOT Analysis
9.5.6 Johnson andamp; Johnson Recent Developments
9.6 CSL
9.6.1 CSL Live Attenuated Vaccines Basic Information
9.6.2 CSL Live Attenuated Vaccines Product Overview
9.6.3 CSL Live Attenuated Vaccines Product Market Performance
9.6.4 CSL Business Overview
9.6.5 CSL Recent Developments
9.7 Sanofi
9.7.1 Sanofi Live Attenuated Vaccines Basic Information
9.7.2 Sanofi Live Attenuated Vaccines Product Overview
9.7.3 Sanofi Live Attenuated Vaccines Product Market Performance
9.7.4 Sanofi Business Overview
9.7.5 Sanofi Recent Developments
9.8 Serum Institute Of India
9.8.1 Serum Institute Of India Live Attenuated Vaccines Basic Information
9.8.2 Serum Institute Of India Live Attenuated Vaccines Product Overview
9.8.3 Serum Institute Of India Live Attenuated Vaccines Product Market Performance
9.8.4 Serum Institute Of India Business Overview
9.8.5 Serum Institute Of India Recent Developments
10 Live Attenuated Vaccines Market Forecast by Region
10.1 Global Live Attenuated Vaccines Market Size Forecast
10.2 Global Live Attenuated Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Live Attenuated Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Live Attenuated Vaccines Market Size Forecast by Region
10.2.4 South America Live Attenuated Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Live Attenuated Vaccines by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Live Attenuated Vaccines Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Live Attenuated Vaccines by Type (2024-2029)
11.1.2 Global Live Attenuated Vaccines Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Live Attenuated Vaccines by Type (2024-2029)
11.2 Global Live Attenuated Vaccines Market Forecast by Application (2024-2029)
11.2.1 Global Live Attenuated Vaccines Sales (K MT) Forecast by Application
11.2.2 Global Live Attenuated Vaccines Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings